These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 32047280)

  • 21. CORRELATION BETWEEN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AND VISUAL OUTCOMES AFTER ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Lee H; Ji B; Chung H; Kim HC
    Retina; 2016 Mar; 36(3):465-75. PubMed ID: 26076214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PREDICTORS OF RETINAL PIGMENT EPITHELIUM TEAR DEVELOPMENT AFTER TREATMENT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION USING SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
    Yasuhara S; Miyata M; Ooto S; Tamura H; Ueda-Arakawa N; Uji A; Muraoka Y; Miyake M; Takahashi A; Wakazono T; Yamashiro K; Tsujikawa A
    Retina; 2022 Jun; 42(6):1020-1027. PubMed ID: 35125477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors Influencing the Treatment Response of Pigment Epithelium Detachment in Age-Related Macular Degeneration.
    Dirani A; Ambresin A; Marchionno L; Decugis D; Mantel I
    Am J Ophthalmol; 2015 Oct; 160(4):732-8.e2. PubMed ID: 26144701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anti-VEGF-therapy of fibrovascular and serous-vascularized pigment epithelial detachment in neovascular AMD : A retrospective five-year-analysis].
    Barth T; Reiners M; Zeman F; Greslechner R; Helbig H; Gamulescu MA
    Ophthalmologe; 2021 Dec; 118(12):1255-1263. PubMed ID: 33320292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvements of Retinal Sensitivity after Intravitreal Injection of Aflibercept in Eyes with Neovascular Age-Related Macular Degeneration with or without Polypoidal Choroidal Vasculopathy.
    Nizawa T; Kitahashi M; Baba T; Iwase T; Kubota-Taniai M; Hattori Y; Shiko Y; Kawasaki Y; Iwase T; Sato T; Ogawa S; Sugawara T; Yamamoto S
    Ophthalmologica; 2021; 244(4):347-360. PubMed ID: 34015785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration.
    Schmidt-Erfurth U; Waldstein SM; Deak GG; Kundi M; Simader C
    Ophthalmology; 2015 Apr; 122(4):822-32. PubMed ID: 25578255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel volumetric imaging biomarkers for assessing disease activity in eyes with PCV.
    Vyas CH; Cheung CMG; Jordan-Yu JMN; Shimizu H; Tan ACS; Sim SS; Fenner BJ; Akiba M; Chakravarthy U; Teo KYC
    Sci Rep; 2022 Feb; 12(1):2993. PubMed ID: 35194070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the effects of anti-vascular endothelial growth factor treatments on pigment epithelial detachment in age-related macular degeneration.
    Ulusoy MO; Kal A; Yilmaz G
    Int Ophthalmol; 2021 Apr; 41(4):1363-1372. PubMed ID: 33481151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photodynamic therapy with verteporfin for age-related macular degeneration or polypoidal choroidal vasculopathy: comparison of the presence of serous retinal pigment epithelial detachment.
    Saito M; Iida T; Nagayama D
    Br J Ophthalmol; 2008 Dec; 92(12):1642-7. PubMed ID: 18782798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with large retinal pigment epithelial detachment in age-related macular degeneration.
    el Matri L; Chebil A; Kort F; Bouraoui R; Baklouti K; Mghaieth F
    Graefes Arch Clin Exp Ophthalmol; 2010 Jun; 248(6):779-84. PubMed ID: 20169357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors and clinical significance of prechoroidal cleft in eyes with neovascular age-related macular degeneration in Caucasian patients.
    Kredi G; Iglicki M; Gomel N; Hilely A; Loewenstein A; Habot-Wilner Z; Zur D
    Acta Ophthalmol; 2023 May; 101(3):e338-e345. PubMed ID: 36259092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognostic factors of antiangiogenic therapy response in neovascular macular degeneration].
    Fursova AZ; Chubar NV; Tarasov MS; Vasilyeva MA; Pustovaya GG; Saifullina IF
    Vestn Oftalmol; 2018; 134(1):48-55. PubMed ID: 29543199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections.
    Chan CK; Abraham P; Meyer CH; Kokame GT; Kaiser PK; Rauser ME; Gross JG; Nuthi AS; Lin SG; Daher NS
    Retina; 2010 Feb; 30(2):203-11. PubMed ID: 19952998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intravitreal aflibercept in high retinal pigment epithelial detachments].
    Boriskina LN; Khzardzhan YY; Zotov AS; Balalin AS; Kuznetsova NV
    Vestn Oftalmol; 2018; 134(5):92-98. PubMed ID: 30499545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers of optical coherence tomography in evaluating the treatment outcomes of neovascular age-related macular degeneration: a real-world study.
    Lai TT; Hsieh YT; Yang CM; Ho TC; Yang CH
    Sci Rep; 2019 Jan; 9(1):529. PubMed ID: 30679743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two-year course of subfoveal pigment epithelial detachment in eyes with age-related macular degeneration and visual acuity better than 20/40.
    Baba T; Kitahashi M; Kubota-Taniai M; Oshitari T; Yamamoto S
    Ophthalmologica; 2012; 228(2):102-9. PubMed ID: 22508168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spatial Correspondence Between Intraretinal Fluid, Subretinal Fluid, and Pigment Epithelial Detachment in Neovascular Age-Related Macular Degeneration.
    Klimscha S; Waldstein SM; Schlegl T; Bogunovic H; Sadeghipour A; Philip AM; Podkowinski D; Pablik E; Zhang L; Abramoff MD; Sonka M; Gerendas BS; Schmidt-Erfurth U
    Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4039-4048. PubMed ID: 28813577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term visual outcome of pigment epithelial tears in association with anti-VEGF therapy of pigment epithelial detachment in AMD.
    Gutfleisch M; Heimes B; Schumacher M; Dietzel M; Lommatzsch A; Bird A; Pauleikhoff D
    Eye (Lond); 2011 Sep; 25(9):1181-6. PubMed ID: 21701525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dexamethasone implant prior to anti-VEGF therapy in pigment epithelium detachments with high-risk rupture characteristics secondary to neovascular age-related macular degeneration.
    Burgos-Blasco B; Güemes-Villahoz N; Hernández-Ruiz S; Donate-Lopez J; López-Guajardo L
    Arch Soc Esp Oftalmol (Engl Ed); 2022 Dec; 97(12):676-683. PubMed ID: 35879177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RETINAL PIGMENT EPITHELIAL TEAR AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION: Clinical Course and Long-Term Prognosis.
    Heimes B; Farecki ML; Bartels S; Barrelmann A; Gutfleisch M; Spital G; Lommatzsch A; Pauleikhoff D
    Retina; 2016 May; 36(5):868-74. PubMed ID: 26655607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.